Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

FSL2 Post Approval Study for Pediatric and Young Adults Patients

NCT: NCT04959552 · ACTIVE_NOT_RECRUITING

NCT IDNCT04959552
StatusACTIVE_NOT_RECRUITING
Start Date2021-06-01
Completion2026-12-30

Brief Summary

This is a prospective, multi-center, non-randomized, single-arm study intended to characterize the safety of the FreeStyle Libre 2 Flash Glucose Monitoring System when used to manage diabetes in pediatric and young adult patient populations.

Frequently Asked Questions

What is FSL2 Post Approval Study for Pediatric and Young Adults Patients?

FSL2 Post Approval Study for Pediatric and Young Adults Patients is a clinical trial registered under NCT04959552. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04959552?

The current status of NCT04959552 (FSL2 Post Approval Study for Pediatric and Young Adults Patients) is: ACTIVE_NOT_RECRUITING.

When did FSL2 Post Approval Study for Pediatric and Young Adults Patients start?

FSL2 Post Approval Study for Pediatric and Young Adults Patients started on 2021-06-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑